- 1-10 Employees
- Based in Melbourne, Australia
Amplia Therapeutics Limited is a pharmaceutical company advancing a pipeline of FAK inhibitors for cancer and fibrosis. The lead molecule, AMP945, is a “pure play” inhibitor with superior specificity.
Most Recent Annual Report
2022 Annual Report
Older/Archived Annual Reports